Comparing the current results to its competitors, Cerus reported Revenue increase in the 1 quarter 2026 by 24.68 % year on year, while most of its competitors have experienced contraction in revenues by -0.29 %, achieved in the same quarter.
Cerus Corporation, slower than the average decrease reported by the company's competitors of -52.23 %. recorded a net loss and most of the company's competitors saw a decline in earnings by -52.23 %
June 21, 2024
CONCORD, Calif. - Cerus Corporation (Nasdaq:CERS), a global leader in blood transfusion safety, has proudly announced their upcoming lunch symposium and selection of abstracts at the highly anticipated 38th International Congress of the International Society of Blood Transfusion (ISBT). This prestigious event is set to take place in beautiful Barcelona, Spain, from June 23 through June 27, attracting transfusion medicine experts and professionals from around the globe.Cerus Corporation s active participation at this renowned congress represents a significant milestone for the company. The selected presentations and abstracts of interest for Cerus are expected to garner attention from attendees due to their p...
June 14, 2024
Cerus Corporation Celebrates World Blood Donor Day 2024: Recognizing the Vital Role of Blood Donors and Addressing Challenges in Ensuring Access to Safe Blood TransfusionWorld Blood Donor Day (WBDD) has been celebrated on June 14 every year since 2005, and in 2024, Cerus Corporation (Nasdaq: CERS) joins in the acknowledgment and appreciation of blood donors worldwide. As a global leader in blood safety solutions, Cerus recognizes the critical role that blood donors play in ensuring a sufficient supply of safe blood for patients in need. This year, WBDD focuses on honoring all blood donors and addressing the challenges faced in this life-saving mission.Blood transfusion is an essential medical procedure that ...
Carlisle Companies Incorporated operates as a diversified manufacturing company that supplies a range of products to various industries globally. Its business model is focused on acquiring and integrating companies that manufacture niche products and possess expertise in their respective markets. By leveraging these acquisitions, Carlisle aims to generate consistent revenue growth and enhance its profitability through operational efficiencies and market expansion opportunities.
Precision Optics Corporation Inc is a company that specializes in designing and manufacturing advanced optical systems for medical and defense industries. They focus on delivering high-precision solutions to meet the complex optical needs of their customers.
Haemonetics Corporation's business model revolves around providing innovative solutions and technologies for the collection, processing, and management of blood and its components.
Grifols SA operates a business model that focuses on plasma-derived medicine production and commercialization, including plasma collection, testing, and fractionation, as well as the development of diagnostic equipment and transfusion medicine. Their core activities involve the extraction of plasma, transforming it into life-saving therapies, and distributing them worldwide to healthcare providers.
Cytosorbents Corporation operates on a business model that focuses on the development and commercialization of novel products for blood purification. The company manufactures and sells its flagship product, CytoSorb, which is a blood purification technology designed to reduce cytokine storm in critically ill patients. Cytosorbents generates revenue by selling CytoSorb to hospitals, clinics, and healthcare providers globally.
Sources:
Cerus Corporation’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Cerus Corporation versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
